Five novel mutations in the ADAR1 gene associated with dyschromatosis symmetrica hereditaria
Tóm tắt
Dyschromatosis symmetrica hereditaria (DSH) is an autosomal dominantly inherited skin disease associated with mutations of ADAR1, the gene that encodes a double-stranded RNA-specific adenosine deaminase. The purpose of this study was to investigate the potential mutations in ADAR1 in seven Chinese families with DSH. All the coding exons including adjacent intronic as well as 5′ and 3′ untranslated region (UTR) of ADAR1 were screened by direct sequencing. Moreover, quantitative reverse-transcription polymerase chain (qRT-PCR) and Western blot were applied to determine the pathogenic effects associated with the mutations. Molecular genetic investigations detected five novel mutations (c.556C > T, c.3001C > T, c.1936_1937insTG, c.1065_1068delGACA and c.1601G > A resulting in p.Gln186X, p.Arg1001Cys, p.Phe646LeufsX16, p.Asp357ArgfsX47 and p.Gly471AspfsX30 protein changes, respectively) as well as two previously reported (c.2744C > T and c.3463C > T causing p.Ser915Phe and p.Arg1155Trp protein changes, respectively). Among them, we found that the substitution c.1601G > A at the last nucleotide of exon 2 compromised the recognition of the splice donor site of intron 2, inducing an aberrant transcript with 190-bp deletion in exon 2 and causing an approximately 50% reduction of ADAR1 mRNA level in affected individual. In addition, consistent with the predicted results, the expression patterns of other novel mutations were detected by Western blot. We identified five novel and two recurrent mutations of the ADAR1 gene in seven Chinese families with DSH and investigated potential effects of the novel mutations in this study. Our study expands the database on mutations of ADAR1 and for the first time, demonstrates the importance of exonic nucleotides at exon-intron junctions for ADAR1 splicing.
Tài liệu tham khảo
Miyamura Y, Suzuki T, Kono M, Inagaki K, Ito S, Suzuki N, Tomita Y: Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet. 2003, 73: 693-699.
Suzuki N, Suzuki T, Inagaki K, Ito S, Kono M, Horikawa T, Fujiwara S, Shiko A, Matsunaga K, Aoyama Y, Tosaki-Ichikawa H, Tomita Y: Ten novel mutations of the ADAR1 gene in Japanese patients with dyschromatosis symmetrica hereditaria. J Invest Dermatol. 2007, 127: 309-311.
Kondo T, Suzuki T, Mitsuhashi Y, Ito S, Kono M, Komine M, Akita H, Tomita Y: Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: histological observation and comparison of genotypes and clinical phenotypes. J Dermatol. 2008, 35: 395-406.
Hou YX, Chen JJ, Gao M, Zhou FS, Du WH, Shen KJ, Yang S, Zhang XJ: Five novel mutations of RNA-specific adenosine deaminase gene with dyschromatosis symmetrica hereditaria. Acta Derm Venereol. 2007, 87: 18-21.
Liu Q, Jiang L, Liu WL, Kang XJ, Ao Y, Sun M, Luo Y, Song Y, Lo WH, Zhang X: Two novel mutations and evidence for haploinsufficiency of the ADAR gene in dyschromatosis symmetrica hereditaria. Br J Dermatol. 2006, 154: 636-642.
Gao JL, Liu Q, Liu X, Ji CY, Qu SQ, Wang SS, Luo Y: Cyclin G2 suppresses estrogen-mediated osteogenesis through inhibition of Wnt/β-catenin signaling. PLoS One. 2014, 9 (3): e89884-
Liu Q, Liu X, Gao J, Shi X, Hu X, Wang SS, Luo Y: Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation. Int J Biol Sci. 2013, 9 (6): 541-549.
Li CR, Li M, Ma HJ, Luo D, Yang LJ, Wang DG, Zhu XH, Yue XZ, Chen WQ, Zhu XY: A new arginine substitution mutation of DSRAD gene in a Chinese family with dyschromatosis symmetrica hereditaria. J Dermatol Sci. 2005, 37 (2): 95-99.
Murata I, Hozumi Y, Kawaguchi M, Katagiri Y, Yasumoto S, Kubo Y, Fujimoto W, Horikawa T, Kondo T, Kono M, Tomita Y, Suzuki T: Four novel mutations of the ADAR1 gene in dyschromatosis symmetrica hereditaria. J Dermatol Sci. 2009, 53: 76-77.
Wang Q: RNA editing catalyzed by ADAR1 and its function in mammalian cells. Biochemistry (Mosc). 2011, 76: 900-911.
Bass BL: RNA editing by adenosine deaminases that act on RNA Annu. Rev Biochem. 2002, 71: 817-846.
Brooks PJ: The case for 8, 5′-cyclopurine-2′-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience. 2007, 145: 1407-1417.
Liu Q, Liu W, Jiang L, Sun M, Ao Y, Zhao X, Song Y, Luo Y, Lo WH, Zhang X: Novel mutations of the RNA-specific adenosine deaminase gene (DSRAD) in Chinese families with dyschromatosis symmetrica hereditaria. J Invest Dermatol. 2004, 122: 896-899.
Cho DS, Yang W, Lee JT, Shiekhatter R, Murray JM, Nishikura K: Requirement of dimerization for RNA editing activity of adenosine deaminase acting on RNA. J Biol Chem. 2003, 278: 17093-17102.
Kantaputra PN, Chinadet W, Ohazama A, Kono M: Dyschromatosis symmetrica hereditaria with long hair on the forearms, hypo/hyperpigmented hair, and dental anomalies: report of a novel ADAR1 mutation. Am J Med Genet A. 2012, 158A (9): 2258-2265.
Murata I, Hayashi M, Hozumi Y, Fujii K, Mitsuhashi Y, Oiso N, Fukai K, Kuroki N, Mori Y, Utani A, Tomita Y, Fujita Y, Suzuki T: Mutation analyses of patients with dyschromatosis symmetrica hereditaria: five novel mutations of the ADAR1 gene. J Dermatol Sci. 2010, 58: 218-220.
Wang XP, Liu Y, Wang JM, Xiao SX: Two novel splice site mutations of the ADAR1 gene in Chinese families with dyschromatosis symmetrica hereditaria. J Dermatol. 2010, 37: 1051-1052.
Li M, Jin C, Yang L, Lai M, Yao Z: A novel complex insertion-deletion mutation in ADAR1 gene in a Chinese family with dyschromatosis symmetrica hereditaria. J Eur Acad Dermatol Venereol. 2011, 25: 743-746.
Wang XP, Wang WJ, Wang JM, Liu Y, Xiao SX: Four novel and two recurrent mutations of the ADAR1 gene in Chinese patients with dyschromatosis symmetrica hereditaria. J Dermatol Sci. 2010, 58: 217-218.
Liu H, Fu XA, Yu YX, Yu GQ, Yan XX, Liu HX, Tian HQ, Zhang FR: Identification of two novel splice mutations of the ADAR1 gene in two Chinese families with dyschromatosis symmetrica hereditaria. Clin Exp Dermatol. 2011, 36: 797-799.
Kono M, Akiyama M, Kondo T, Suzuki T, Suganuma M, Wataya-Kaneda M, Lam J, Shibaki A, Tomita Y: Four novel ADAR1 gene mutations in patients with dyschromatosis symmetrica hereditaria. J Dermatol. 2012, 39: 819-821.
Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, Lizasa H, Davuluri RV, Nishikura K: ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell. 2013, 153 (3): 575-589.
Qiu W, Wang X, Buchanan M, He K, Sharma R, Zhang L, Wang Q, Yu J: ADAR1 is essential for intestinal homeostasis and stem cell maintenance. Cell Death Dis. 2013, 4: e599-
Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirch J, Jacoby E, Rivkin L, Eyal E, Prieto VG, Chakravarti N, Duncan LM, Kallenberg DM, Galun E, Bennett DC, Amariglio N, Bar-Eli M, Schachter J, Rechavi G, Markel G: MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest. 2013, 123 (6): 2703-2718.
Nishikura K, Sakurai M, Ariyoshi K, Ota H: Antagonistic and stimulative roles of ADAR1 in RNA silencing. RNA Biol. 2013, 10 (8): 1240-1247.
Tojo K, Sekijima Y, Suzuki T, Suzuki N, Tomita Y, Yoshida K, Hashimoto T, Ikeda S: Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation. Mov Disord. 2006, 21: 1510-1513.
Rice GI, Kasher PR, Fort GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, Jenkinson EM, Bacino CA, Battini R, Bertini E, Brogan PA, Brueton LA, Carpanelli M, De Laet C, de Lonlay P, del Toro M, Desquerre I, Fazzi E, Garcia-Cazorla A, Heiberg A, Kawaquchi M, Kunar R, Lin JP, Lourenco CM, Male AM, Marques W, et al: Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet. 2012, 44: 1243-1248.
Suzuki N, Suzuki T, Inagaki K, Ito S, Kono M, Fukai K, Takama H, Sato K, Ishikawa O, Abe M, Shimizu H, Kawai M, Horikawa T, Yoshida K, Matsumoto K, Terui T, Tsujioka K, Tomita Y: Mutation analysis of the ADAR1 gene in dyschromatosis symmetrica hereditaria and genetic differentiation from both dyschromatosis universalis hereditaria and acropigmentatio reticularis. J Invest Dermatol. 2005, 124: 1186-1192.
Zhang JY, Chen XD, Zhang Z, Wang HL, Guo L, Liu Y, Zhao XZ, Cao W, Xing QH, Shao FM: The adenosine deaminase acting on RNA 1 p150 isoform is involved in the pathogenesis of dyschromatosis symmetrica hereditaria. Br J Dermatol. 2013, 169 (3): 637-644.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/15/69/prepub